Evidence map›Paper›PMID 37577603›Full record

ArticleResearch square2023

MethNet: a robust approach to identify regulatory hubs and their distal targets in cancer.

Theodore Sakellaropoulos, Catherine Do, Guimei Jiang, Giulia Cova, Peter Meyn, Dacia Dimartino, Sitharam Ramaswami, Adriana Heguy, Aristotelis Tsirigos, Jane A Skok

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Theodore SakellaropoulosDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
Catherine DoDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
Guimei JiangDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
Giulia CovaDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-6489-8807
Peter MeynGenome Technology Center, NYU Grossman School of Medicine, New York, NY, USA.
Dacia DimartinoGenome Technology Center, NYU Grossman School of Medicine, New York, NY, USA.
Sitharam RamaswamiGenome Technology Center, NYU Grossman School of Medicine, New York, NY, USA.
Adriana HeguyGenome Technology Center, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-2836-6683
Aristotelis TsirigosDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-7512-8477
Jane A SkokDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-4145-1516
NYU Langone Health · USHinge Health · USNew York Genome Center · USOffice of Science · US

Funding

The impact of changes in chromatin architecture on cancer phenotypes and tumor progressionP01CA229086 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 2019 to 2026
$17.0M
Nuclear organization and its role in gene regulationR35GM122515 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Jane Amanda Skok · 2017 to 2026
$7.1M
NCI NIH HHS P01 CA229086NIGMS NIH HHS R35 GM122515
6 · The paper itself

Abstract

Aberrations in the capacity of DNA/chromatin modifiers and transcription factors to bind non-coding regions can lead to changes in gene regulation and impact disease phenotypes. However, identifying distal regulatory elements and connecting them with their target genes remains challenging. Here, we present MethNet, a pipeline that integrates large-scale DNA methylation and gene expression data across multiple cancers, to uncover novel cis regulatory elements (CREs) in a 1Mb region around every promoter in the genome. MethNet identifies clusters of highly ranked CREs, referred to as 'hubs', which contribute to the regulation of multiple genes and significantly affect patient survival. Promoter-capture Hi-C confirmed that highly ranked associations involve physical interactions between CREs and their gene targets, and CRISPRi based scRNA Perturb-seq validated the functional impact of CREs. Thus, MethNet-identified CREs represent a valuable resource for unraveling complex mechanisms underlying gene expression, and for prioritizing the verification of predicted non-coding disease hotspots.

Identifiers

PMID37577603
PMCPMC10418566
OpenAlexW4385399820

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.